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Abstract: 
Bioorthogonal chemistry is an effective tool for measuring metabolic pathways and cellular activity, yet 
its use is currently limited due to the difficulty of introducing probes past the cell membrane and into the 
cytoplasm, especially as more complex probes are desired. Here we present a simple and minimally 
perturbative technique to deliver functional probes of glycolysylation into cells using a nanostructured 
“nanostraw” delivery system. Nanostraws provide large scale intracellular access to cells through fluidic 
conduits that remain small enough to minimize cell perturbation. First, we demonstrate that our platform 
can deliver an unmodified azidosugar, N-azidoacetylmannosamine, into cells with similar effectiveness as 
a chemical modification strategy (peracetylation). We then show that for an azidosugar modified with a 
charged uridine diphosphate group (UDP) that prevents intracellular penetration, the nanostraw platform 
enables its direct delivery into cells, thus bypassing multiple enzymatic processing steps. By effectively 
removing the cell permeability requirement from the probe, the nanostraws expand the toolbox of 
bioorthogonal probes to study biological processes using a single, easy-to-use platform. 
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Introduction 
Metabolic labeling has become a critical tool for tracking the passage and function of biological substrates, 
yet has been limited by the difficulty of cellular delivery. Early experiments using radio-labeled analogs of 
glucose and nucleotides allowed researchers to identify their downstream biological products in 
metabolism and DNA replication1-2. More recently, metabolic labeling has been widely applied to study 
post-translational modifications (PTMs). PTM archetypes range from small functional group adornments 
such as phosphate and methyl groups to larger-scale assemblages such as ubiquitination and 
glycosylation3-4. By actively and reversibly modulating protein function, PTMs are essential for intracellular 
energy exchange, epigenetic memory, and signal transduction. As the study of PTMs has expanded, so too 
has the demand for observation of their localization and dynamics, driving the search for new functional 
metabolic analogs5-7.  
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Recently, a versatile approach has emerged, combining metabolic labeling with bioorthogonal chemistry8-
9. With this strategy, metabolic analogs bearing a sterically-minimized bioorthogonal functional group 
“handle” must be delivered into cells. Once inside the cytoplasm, the handle is specifically labeled with a 
fluorophore by a bioorthogonal ligation reaction. This method has been especially effective for protein 
glycosylation studies.  Natural glycosylation patterns are among the most complex and variable PTMs, 
composed of many unique monosaccharide subunits attached in linear and branching patterns. Their 
composition can vary dramatically, and these changes in composition correlate with dramatically altered 
phenotypes, as evidenced by the altered glycosylation status of cancer cells10. Bioorthogonal labeling 
provides the resolution, live-cell compatibility, and multiplexed detection necessary to map the 
relationship between glycosylation patterns and behavior in cells11-12. 
The key barrier to this flexible labeling scheme is delivery of the metabolic analogs through the cell 
membrane and into the cytoplasm. Chemical modifications or adjuvants such as peracetylation13-14 or 
permeabilizing agents7, 15-16 can help to increase delivery effectiveness, but are not universally applicable 
and may engender cytotoxicity17 and lower efficiency of labeling. Moreover, the kinetics of enzymatic 
reactions being probed with metabolic analogs are often unknown and the intracellular levels of a 
metabolite may require constant upkeep over several days9. Unfortunately, most intracellular delivery 
agents are designed for single-shot delivery of oligonucleotide cargo and are too disruptive to be 
repeatedly applied, making them significantly less effective for consistent, extended metabolic labeling. 
Without more effective strategies for delivery, the full range of bioorthogonal probes remains untapped 
and delivery of available probes is suboptimal. 
Here, we present a simple, non-perturbative technique to deliver poorly membrane permeable azido-
functionalized monosaccharides into cells where they can be metabolized onto glycoproteins and labeled 
using bioorthogonal chemistry18. This technique uses a nanostructured platform of supported hollow 
tubes, called nanostraws, which deliver membrane impermeable molecules directly into the cytoplasm 
with minimal cell disruption19-22. We first show that nanostraws enable the efficient delivery of N-
azidoacetylmannosamine (ManNAz) at comparable levels to what can be achieved by chemical 
modification (peracetylation). More importantly, we show that nanostraws enable the delivery of another 
metabolite, UDP-N-azidoacetylgalactosamine (UDP-GalNAz). This molecule is an intermediate in the 
glycosylation pathway and is currently lacking effective strategies for delivery in cultured mammalian 
cells, but with nanostraw delivery it can be further exploited as a carrier for complex functional groups or 
tags that are incompatible with upstream biosynthetic enzymes. By directly penetrating cells to deliver 
cargo into the cytoplasm, nanostraws represent a powerful new approach to introduce cell-impermeable 
bioorthogonal probes into cellular studies. We demonstrate this using azidosugars but nanostraws are 
cargo-agnostic, enabling generic delivery and unlocking the study of many other biological systems. 
Results and Discussion 
Nanostraw membranes are polycarbonate membranes with randomly arranged hollow pores spanning 
the thickness of the membrane19. The pores were created using a track-etching procedure, making them 
highly uniform along their length with well-controlled diameters. Following deposition of aluminum oxide 
by atomic layer deposition and two selective etching steps, a forest of nanostraws (~3*107cm-2) was 
formed on the membrane. The nanostraws themselves are hollow alumina tubes 100 nm in outer 
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diameter, 10 nm in wall thickness, and 1.5-2 µm in height. These tubes are embedded in the polycarbonate 
polymer substrate (Figure 1), making them stable and creating an attractive surface for cell adhesion.  
Due to mechanical forces, a fraction of the nanostraws will directly penetrate the cells cultured onto 
them21, 23, yet their small size and long leakage path largely limits cell perturbation19.  Penetrant 
nanostraws act as conduits across the membrane, enabling molecules in solution on one side of the 
membrane to diffuse through the nanostraws to the other side (Figure 1B). As substrates for cell culture, 
nanostraws and related nanowires are robust in their materials properties and generally non-toxic, 
although some perturbations in cell behavior have been observed24-26. Previous applications of 
nanostraws have included delivery of small molecules, DNA, membrane impermeable dyes19, and ions20-
21, 27.  
For delivery of azidosugars, the nanostraw membranes were assembled into devices consisting of a cell 
culture well, an adhesive layer, the nanostraw membrane, and a delivery chamber (Figure 1A, 
Supplemental Figure 1A). The cell culture well is a plastic tube with an approximately 8 mm inner diameter 
that holds 300 µL of culture media, but can be scaled up or down to accommodate lesser or greater 
numbers of cells (Supplemental Figure 1B). The nanostraw membrane, which is uniform over sizes up to 
several centimeters squared, is attached to the culture well with a ring of double-sided, biocompatible 
tape for the adhesive layer, providing a water-tight seal. The nanostraw membrane itself is approximately 
20 µm thick and serves as the cell culture substrate. The delivery chamber is then created using a second 
ring of double sided tape, to store approximately 20 µl of cargo solution. This assembled device allows for 
cells to be cultured onto the membrane with access to the cargo chamber through the nanostraw 
conduits. Control experiments were conducted with flat membranes with the same density of pores but 
no protruding nanostraws. Reagents to be delivered were pipetted beneath the nanostraw membrane, 
and allowed to diffuse into the cells.  
To demonstrate delivery of a bioorthogonal chemistry probe into cells using nanostraws we delivered 
ManNAz, which results in the introduction of azide groups onto sialylated cell surface proteins (Figure 1B). 
Upon incorporation onto surface glycoproteins, the azide moieties of metabolized ManNAz can be 
specifically labeled with fluorescent click chemistry probes (fluorophore- conjugated dibenzylcyclooctyne, 
DBCO). Importantly, a peracetylated derivative of ManNAz (Ac4ManNAz), shown to be orders of 
magnitude more effective in biosynthetic incorporation compared to the parent compound9, serves as a 
point of comparison for the efficacy of nanostraw delivery. The cell permeable Ac4ManNAz should label 
cell glycans when presented to cells in solution, while equal concentrations of the less permeable ManNAz 
would require a delivery method such as the nanostraws to provide the same labeling. Confirming earlier 
work, Chinese hamster ovary (CHO) cells incubated in control tests in standard 96-well plates with 
Ac4ManNAz (100 µM for 48 hours, 10 µM Cy3 DBCO label) showed a characteristic cell-surface 
fluorescence profile after the bioorthogonal labeling reaction (Supplemental Figure 2A). However, cells 
incubated with cell-impermeant ManNAz under identical conditions showed only faint fluorescent 
staining (Supplemental Figure 2B). 
To prepare devices for nanostraw delivery, nanostraw and flat membrane control devices were prepared 
by a plasma clean (<1 minute) after assembly, followed by an overnight UV light exposure and 3 hour 
incubation with 50 µL poly-lysine or poly-ornithine (150 µM). Following a 3x wash in PBS, 100,000 CHO 
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cells were resuspended in DMEM supplemented with 10% FBS and plated on the device. A 20 µL drop of 
ManNAz solution was placed on parafilm and the device was placed on top, to fill the delivery chamber.  
Nanostraw delivery of ManNAz was tested for two delivery time scales: a long incubation of 48 hours 
(Figure 2A-C) and a short incubation of 4 hours (Figure 2D-F). The ManNAz concentration in PBS was either 
1 mM for the long incubation or 10 mM for the short incubation. After incubation, the media was removed 
from the culture chamber and the delivery chamber was washed in PBS to remove excess ManNAz 
solution. The culture well was incubated in PBS with 1% FBS for 5 minutes, rinsed 2x with PBS and 
incubated in 50 µM Carboxyrhodamine 110 DBCO or Cy3 DBCO in phenol red-free DMEM for 15 minutes 
at 37 °C. Following DBCO incubation, the culture chamber was rinsed 3x with PBS and incubated in 0.25% 
Trypsin with EDTA for 10 minutes, and the trypsinized cells were replated onto cover slips coated with 
poly-lysine. After 4 hours to allow cells to adhere, slides were washed in PBS to remove excess fluorescent 
labels, fixed in 4% paraformaldehyde, and mounted for imaging. 
Imaging of cell-impermeable ManNAz delivery after the long 48 hour incubation shows a distinct contrast 
between strong DBCO labeling after ManNAz delivery on nanostraw devices (Figure 2A) relative to the 
weaker fluorescence observed on flat membrane devices (Figure 2B). The line profile trace across cells 
also demonstrates a substantial increase in fluorescence intensity on nanostraw devices relative to flat 
membrane devices (Figure 2C). Some variations in cell-to-cell fluorescence were observed as nanostraw 
based delivery systems have demonstrated an inherent spread in delivery cell-to-cell21, and the 
nanostraws show markedly increased retention of cells due to improved cell adhesion to nanostraws and 
similar nanowires during washing steps28. A small amount of ManNAz uptake is observed even on flat 
membrane devices due to non-specific uptake mechanisms, but non-specific uptake is unreliable and the 
characteristic cell-border fluorescence profile is much weaker. 
Delivery using the shorter 4 hour incubation reveals that cell-surface labeling had already occurred on 
nanostraw devices (Figure 2D) in contrast to indistinct labeling on flat membrane devices (Figure 2E). The 
raw difference in intensity is lower at 4 hours compared to 48 hours (Figure 2F), which is consistent with 
increased labeling of accumulated azido groups over the longer time period. 
These results show improved delivery efficiency of poorly permeable azidosugars with nanostraws. While 
a peracetylated, cell-permeable ManNAz analog was available, the true promise of nanostraws lies in 
facile delivery of metabolites that are difficult or infeasible to chemically modify. Within this class of 
metabolites are UDP-modified sugars, which bear a negatively charged diphosphate linkage that limits cell 
permeability. UDP-sugars are biosynthesized through multiple enzymatic steps from the free 
monosaccharide to be directly attached onto proteins via glycosyltransferases29.  
Direct delivery of UDP-sugars into the cytoplasm addresses two critical shortcomings. First, by delivering 
cell-impermeable secondary metabolites such as UDP-sugars and not their precursors, the activity of 
specific downstream enzymes within the pathway, glycosyltransferases in this instance, can be directly 
probed. Second, although complex functional groups such as UDP groups and fluorophores can be easily 
attached to free monosaccharides, the resulting modified, bulkier metabolite is often rejected by one or 
more of the enzymes required for biosynthetic processing and incorporation of the metabolite into its 
end-product. By directly delivering UDP-sugars into the cytoplasm and bypassing multiple biosynthetic 
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steps, the repertoire of unnatural functionalities to be incorporated onto nascent glycoproteins is freed 
from many enzymatic compatibility constraints.  
We examined whether nanostraws are effective for a larger variety of unnatural substrates by delivering 
three unnatural N-acetyl galactosamine derivatives: peracetylated N-azidoacetylgalactosamine 
(Ac4GalNAz), N-azidoacetylgalactosamine (GalNAz), and the uridine diphosphate modified N-
azidoacetylgalactosamine (UDP-GalNAz), into GFP-labeled CHO cells (Figure 3A). These three molecules 
can potentially enter the N-acetylgalactosamine salvage pathway at different points30. While UDP-GalNAz 
enters at a much later stage than GalNAz, it is significantly less cell permeable and delivery remains a 
critical challenge.    
We studied delivery of all three forms of GalNAz sugars through both nanostraw and flat-membrane 
control devices. For each azidosugar, 500 µM solutions in PBS were added to the delivery chambers, 
incubated for an intermediate time period of 24 hours with 50,000 cells, then washed and labeled with 
10 µM Cy3 DBCO for 20 minutes. Compared to the negative control condition of cells with no added 
azidosugars incubated with DBCO (Figure 3B, inset – GFP fluorescence), the azidosugars were delivered 
and labeled with varying success on nanostraws and flat membranes (Figure 3C-D, inset – GFP 
fluorescence). Using the nanostraws, all three sugars, including negatively charged and therefore highly 
impermeable UDP-GalNAz, entered the cells and were metabolized onto cell surface glycoproteins to 
produce the characteristic cell border fluorescence upon DBCO labeling (Figure 3C). GalNAz and 
Ac4GalNAz delivery using nanostraws were both nearly 100% efficient in CHO cells and comparable to 
ManNAz delivery, while UDP-GalNAz delivery was nearly as effective, with only a small number of cells 
appearing to have weak or no fluorescence.  
On flat control membranes, only Ac4GalNAz, being cell-permeable, was seen around cells after DBCO 
labeling (Figure 3D). Both GalNAz and UDP-GalNAz-delivered cells showed only non-specific fluorescence 
when the sugar was added through a flat membrane, with a similar fluorescence profile as cells with no 
added sugars at all (Figure 3B). In these two negative conditions, GalNAz and UDP-GalNAz delivered 
through flat membranes, as well as the sugar-free condition, some fluorescence was observed, likely due 
to nonspecific uptake of DBCO or labeling of debris. Nanostraws appear to further promote some 
nonspecific labeling in the form of bright, central spots of fluorescence, but this form of labeling is 
accompanied by the circular, cell border labeling characteristic of bioorthogonal labeling of azido-
modified glycoproteins, except in rare cases with UDP-GalNAz delivery. 
These results show that physical cell penetration and delivery through nanostraws is an effective method 
to overcome limitations of cell-impermeant labeling molecules in metabolic labeling studies.  Nanostraw 
delivery of membrane impermeable ManNAz, a well-characterized molecule for studying protein 
glycosylation, reproduced the effect of chemical modification at long and short-term delivery scales.  
The nanostraws also demonstrated the capacity to deliver UDP-GalNAz, an intermediate enzymatic 
byproduct of GalNAz metabolism which cannot be delivered by chemical means. The principle of 
bypassing the cell membrane using nanostraw delivery addresses an essential theme in the application of 
bioorthogonal probes – their potential to be poor substrates for the endogenous biosynthetic 
machinery31. For natural metabolites that require multiple biosynthetic processing and enzymatic steps, 
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a metabolic analog that is incompatible with just one enzyme in the pathway will not appear in 
endogenous biopolymer end-products. To bypass such an enzymatic bottleneck, metabolites further 
downstream in the pathway can be synthesized with the desired bioorthogonal handle. However, these 
downstream metabolites are naturally processed to be retained in cell compartments, often with charged 
groups such as UDP, and are therefore poorly cell permeable, thus requiring an intracellular delivery 
strategy such as the nanostraws32. 
Metabolic analogs that address other pathways of metabolism and post-translational modification are 
also excellent candidates for nanostraw delivery, including modified ATP, which can be used in 
conjunction with modified enzymes to discover new substrates for kinases but suffers from poor delivery 
options33, or synthetic cross-linkers or dimerizing agents, which can induce novel interactions in cells to 
study pathways with increased specificity34. Ultimately, the nanostraws represent a minimally 
perturbative delivery platform capable of delivering a range of freely-diffusing species, and are effective 
for sustained delivery for over 24 hours. Thanks to the availability of the plastic tubes used to define the 
cell culture area and the uniformity of the nanostraws themselves19, the platform is scalable; with delivery 
to cells using a larger nanostraw device, larger scale flow cytometry quantification or mass spectrometry 
experiments for proteomics are possible in the future. Finally, the nanostraws remove the cell 
permeability requirement for chemical probes to relax constraints on size and charge, allowing more 
diverse and effective chemical probes to be brought to bear on biological problems. 
Experimental Section 
Nanostraw and Device Fabrication 
Nanostraws were fabricated using a track-etched membrane template (GVS). The templates were 20 µm 
thick polycarbonate membranes with randomly arranged pores at a density of 3*107 cm-2. Track-etched 
membrane templates are generally available in large volumes at a single prescribed density of extremely 
thin pores only, and are then etched to the desired pore diameter in smaller batches. The nanostraw 
membranes in this study were etched to 100 nm as purchased. Compared to commercially available track-
etched membranes used for water filtration and other applications, the nanostraw membrane templates 
have relatively low porosity, with either a lower pore diameter than membranes with similar pore density 
or a low density than membranes with similar pore diameter. 
Using as purchased membranes, nanostraws were fabricated by coating the templates with atomic layer 
deposition (ALD) alumina. A 10-15 nm layer of alumina is conformally applied to both sides of the 
membrane template as well as the inner walls of the pores using 50 cycles of ALD. Each cycle uses 
alternating pulses of trimethylaluminum (TMA) and water (H2O) with a precursor pulse step of 0.015 s, an 
exposure step of 30 s, and a purge step of 60 s. The Savannah platform (Cambridge Nanotech) 
accommodates up to 4 inch wafer sized membranes, and the nanostraws are typically fabricated in smaller 
area batches to ensure uniformity. The nanostraws that protrude above the membrane were created by 
first etching one alumina coated surface of the membrane using a PlasmaQuest etcher and BCl3 and Cl2 
plasma (40 sccm BCl3, 30 sccm Cl2, 5 sccm Ar at 300 watts, 250 s) to expose the polycarbonate beneath. 
The polycarbonate is then removed using an oxygen plasma etch (SPI Plasma Prep III Solid State, 200 
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mTorr and 100 watts, 40 min). The alumina coating the walls of the membrane pores remains to form the 
free-standing nanostraws. 
The device materials consist of the nanostraw membranes, plastic tubing, and two rings of double-sided 
tape (Digi-key Electronics, 3M Acrylic Foam). The double sided tape was laser-cut to form regular rings, 
and the plastic tubing was polished on both ends to ensure that a water-tight seal is formed. For the lower 
ring of double-sided tape forming the delivery chamber, the plastic covering protecting the lower side of 
the tape is not removed to prevent the device from sticking to surfaces and allow access to the delivery 
chamber to pipette cargo solutions. Besides the nanostraws, the other materials used in the device can 
be easily obtained in bulk quantities and assembled. 
Azidosugar Synthesis 
ManNAz, Ac4ManNAz, GalNAz, Ac4GalNAz, and UDP-GalNAz were synthesized according to literature 
procedure29, 35. 
Cell Culture and Delivery Assays 
CHO cells and GFP-expressing CHO cells were cultured in DMEM supplemented with 10% FBS and 1% 
Penicillin/Streptomycin. Before CHO cells were added to nanostraw devices for delivery, devices were 
placed in oxygen plasma to sterilize, moved to the tissue culture hood, and further exposed to UV 
overnight to ensure sterility. A 2-3 hour incubation with 50 uL poly-lysine or poly-ornithine promoted cell 
adhesion to the nanostraws. After 3x PBS wash to remove excess solution, CHO cells were trypsinized 
using 0.25% trypsin, resuspended in DMEM, and added to the cell culture well. At the device diameter 
used, the delivery chamber stores 20 µL of cargo solution. To fill the delivery chamber, solution was placed 
in a droplet on parafilm, which prevents the solution from spreading. Slowly placing the device on top of 
the droplet ensured that air bubbles were minimized. After the delivery chamber was filled, the devices 
were placed in a humidified petri-dish and returned to the incubator at 37°C. For long term deliveries (>24 
hr) the cargo solution may evaporate and it was necessary to replenish the chamber.  
After incubation, cells are labeled using DBCO fluorophores (Click Chemistry Tools) by first washing away 
excess cargo solution from the delivery chamber with a PBS wash. Following a short blocking step of the 
cell culture chamber using 1% BSA in PBS and 2x PBS wash, DBCO fluorophores were incubated in the cell 
culture chamber for 15 min at 37°C. After a final 3x PBS wash, the cells were prepared for imaging. Due to 
the small volume of the cell culture wells as well as the fragile nature of the nanostraw membrane, 
thorough washing was difficult and care was taken to remove as much liquid as possible without 
puncturing the nanostraw membrane. 
To image cells, cover slips were first prepared by placing a drop of poly-lysine on the cover slip for 15 
minutes. The cover slips were then washed to remove excess solution. DBCO labeled and washed cells 
were resuspended by adding trypsin to the cell culture well. Cells cultured on the flat membranes were 
susceptible to loss during wash steps, while nanostraw-adhered cells were trypsinized for longer time 
periods (~5-10 minutes) to resuspend. After trypsinization, cells were resuspended in media and added 
to the cover slips. Following a 4 hour adherence period, the cover slips were further washed in PBS to 
remove excess DBCO fluorophores, a necessary step due to the washing difficulty described earlier. Cells 
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were then fixed with 4% paraformaldehyde, mounted on a glass slide, and imaged using a confocal 
microscope (Zeiss Axiovert 200 M), photometrics Cascade 512B digital camera (Roper Scientific) and 
MetaMorph software (Molecular Devices).  
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Figures 
 
Figure 1. Nanostraw device used for azidosugar delivery. A) The device consists of four parts: a cell culture 
well, the adhesive layer, the nanostraw membrane, and a delivery chamber. The adhesive produces a 
water-tight seal between the cell culture well and the membrane, so that cargo placed in the delivery 
chamber below can only enter the culture well through the membrane pores. If a nanostraw membrane 
is used and the nanostraws have cellular access, then the cargo may pass directly into cells through 
penetrating nanostraws. B) Upon successful entry into the cell, an azidosugar such as ManNAz is 
enzymatically converted into sialic acid groups and incorporated onto cell surface glycoproteins. These 
groups retain the azide moiety, which can be targeted and labeled using a DBCO fluorophore. 
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 Figure 2. ManNAz delivery using nanostraws. A,B) Cells were labeled and imaged after a long term 48 hr 
incubation of ManNAz on nanostraw and flat membrane devices. C) A line trace shows a strong difference 
in fluorescent intensity between nanostraw delivery and nonspecific uptake. D,E,F) This difference was 
also observed at 4 hrs albeit at reduced intensity. 
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 Figure 3. Delivery of modified unnatural UDP-sugars. A) Flat membrane and nanostraw delivery were 
performed using three sugars, GalNAz, cell-permeable Ac4GalNAz, and negatively charged cell 
impermeable UDP-GalNAz. B) Cells incubated with DBCO fluorescent probes but no azidosugar showed 
some non-specific labeling but no characteristic cell border fluorescence (inset – GFP fluorescence). C) 
When nanostraws were used for delivery, all three forms of GalNAz successfully entered the cells to be 
incorporated onto surface glycoproteins and labeled. D) On flat, control membranes, neither GalNAz nor 
UDP-GalNAz was successfully delivered into cells, but the cell-permeable Ac4GalNAz was metabolized and 
successfully labeled using the click chemistry reaction.  
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